Transdermal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020 Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Transdermal Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020”. Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.

Scope

• Extensive coverage of the Transdermal Drug Delivery Devices under development
• The report reviews details of major pipeline products which includes product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Tables & Figures

2 Introduction

2.1 Transdermal Drug Delivery Overview

3 Products under Development

3.1 Transdermal Drug Delivery – Pipeline Products by Stage of Development

3.2 Transdermal Drug Delivery – Pipeline Products by Segment

3.3 Transdermal Drug Delivery – Pipeline Products by Territory

3.4 Transdermal Drug Delivery – Pipeline Products by Regulatory Path

3.5 Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date

3.6 Transdermal Drug Delivery – Ongoing Clinical Trials

4 Transdermal Drug Delivery – Pipeline Products under Development by Companies

4.1 Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development

4.2 Transdermal Drug Delivery – Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Companies and Product Overview

6 Transdermal Drug Delivery- Recent Developments 2977 Appendix

7 Appendix

Companies Mentioned

• 3M Co
• 4P Therapeutics LLC
• Actuated Medical Inc
• Adynxx Inc
• Aequus Pharmaceuticals Inc
• Agile Therapeutics Inc
• Allergan Ltd
• AMW GmbH
• AngioSoma Inc
• Apogee Technology Inc
• Asahi Kasei Pharma Corp
• ASCIL Biopharm
• Avecho Biotechnology Ltd
• Avro Life Sciences
• Boryung Pharmaceutical Co Ltd
• Burke Pharmaceuticals LLC
• Candesant Biomedical Inc
• Cassava Sciences Inc
• CB Scientific Inc
• Cerimon Pharmaceuticals, Inc. (Inactive)
• Chrono Therapeutics Inc
• Cipla Ltd
• Clexio Biosciences Ltd
• Corium Inc
• Daewoong Pharmaceutical Co Ltd
• DBV Technologies SA
• DD Therapeutics LLC
• Delpor Inc
• Dermisonics Inc (Inactive)
• Dharma Therapeutics, Inc. (Inactive)
• Diomics Corp
• Drexel University
• DURECT Corp
• Echo Therapeutics Inc
• Emplicure AB
• Endo International Plc
• Extend Biosciences Inc
• Fe3 Medical Inc
• Futura Medical Plc
• Georgia Institute of Technology
• Georgia State University
• Hisamitsu Pharmaceutical Co Inc
• I M Sechenov Moscow State Medical University
• Icure Pharmaceutical Inc
• ImmuPatch
• Indian Institute of Science
• Indian Institute of Technology Bombay
• InMed Pharmaceuticals Inc
• Institute of Materials Research & Engineering
• Intercell AG (Inactive)
• Interstitial NS
• Isis Biopolymer Inc (Inactive)
• Janisys
• KTH Royal Institute of Technology
• Leo Pharma AS
• Livzon Pharmaceutical Group Co Ltd
• Lohmann Therapie-Systeme AG
• Luye Pharma Group Ltd
• Massachusetts Institute of Technology
• Mayne Pharma Group Ltd
• Medherant Ltd
• MEDRx Co Ltd
• MedRx, Inc.
• Microdermics Inc
• Micron Biomedical Inc
• Micropoint Technologies Pte Ltd
• mPhase Technologies Inc
• National University of Singapore
• Nemaura Pharma Ltd
• NeuroDerm Ltd
• Nitto Denko Corp
• North Carolina State University
• Noven Pharmaceuticals Inc
• NutriBand Inc
• Nuvo Pharmaceuticals Inc
• PassPort Technologies Inc
• Privo Technologies Inc
• Prometheon Pharma LLC
• Purdue University
• Quoin Pharmaceuticals Ltd
• Radius Health Inc
• Ryah Medtech Inc
• Samyang Biopharmaceuticals Corp
• Scilex Ltd
• Seelos Therapeutics, Inc.
• Shenox Pharmaceuticals LLC
• Sinsin Pharmaceutical Co Ltd
• SK Chemicals Co Ltd
• Skinject Inc
• Sparsha Pharma International Pvt Ltd
• Sree Chitra Tirunal Institute for Medical Sciences & Technology
• Stanford University
• Starton Therapeutics Inc
• Syntropharma Ltd
• Taho Pharmaceuticals Ltd
• Technology Health Inc
• Teikoku Pharma USA Inc
• tesa Labtec GmbH
• Teva Pharmaceutical Industries Ltd
• Texas Tech University
• The Sheikh Zayed Institute for Pediatric Surgical Innovation
• TheraJect Inc
• Therapeutic Systems Research Laboratories Inc
• TheraSolve NV (Inactive)
• Theratech, Inc.
• Thrudermic LLC
• Titan Pharmaceuticals Inc
• Toa Eiyo Ltd
• Transcu Group Limited (Inactive)
• Transdermal Delivery Solutions Corp
• Transdermal Specialties Inc
• TransPharma Medical Ltd (Inactive)
• Transport Pharmaceuticals Inc
• University of Illinois at Chicago
• University of Toronto
• Vaxess Technologies Inc
• Vaxxas Pty Ltd
• Verndari Inc
• ViiV Healthcare UK Ltd
• Virpax Pharmaceuticals Inc
• Vyteris, Inc. (Inactive)
• Xel Pharmaceuticals Inc
• XPhyto Therapeutic Corp
• Zambon Italia Srl
• Z-Cube Srl
• ZetrOZ Inc
• Zynerba Pharmaceuticals Inc

For more information about this report visit https://www.researchandmarkets.com/r/hkw8cx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900